The Center for Medicare and Medicaid Innovation has released a new, voluntary Enhancing Oncology Model (EOM) intended to reduce spending and improve quality of care for cancer patients.  The EOM is a 5-year voluntary model, beginning on July 1, that has payment incentives and requires participant redesign activities. The model will end in June 2028.

NASHVILLE – An estimated three-quarters of physicians are employed by hospitals, according to information released at the HFMA session “Closing the Financial Data Gap in a Physician Alignment Strategy.”

Connecticut Office of Health Strategy is a think tank around health policy in the state, says Sumit Sajnani, health information technology officer at the Connecticut Office of Health Strategy.  

NASHVILLE – Revenue cycle vendor management has saved two health systems millions, according to two vice presidents of revenue cycle speaking at HMFA 2023. Total savings for the Vanderbilt University Medical Center has been $1.9 million to date, according to Heather Dunn, vice president and chief revenue cycle officer. This is a system that has […]

CMS is proposing to increase the end stage renal disease prospective payment base rate to $269.99 for 2024, increasing total payments to freestanding ESRD facilities by $4.42, or approximately 1.6%, compared to 2023. For hospital-based ESRD facilities, CMS projects an increase in total payments of 2.6%.

Working for a nonprofit focused on saving lives and improving the quality of life, Carolina Nelson, the relief organization’s LAC regional deputy director, says she found HIMSS a great space to understand the stakeholders and solutions that could support that mission.

NASHVILLE – Four health system CFOs on Sunday kicked off the opening keynote session of the Healthcare Financial Management Association annual conference by summing up the challenges hospitals have overcome and how they’re tackling the ones ahead.

Optum is acquiring home health, hospice and acuity care provider Amedisys in an all-cash deal valued at an estimated $3.3 billion. The agreement calls for the acquisition of Amedisys’s outstanding common stock in an all-cash transaction for $101 per share, the company said by statement.

The Centers for Medicare and Medicaid Services is releasing new details about how people can get drugs that may slow the progression of Alzheimer’s disease covered by Medicare. If the Food and Drug Administration grants traditional approval, then Medicare will cover the drug in what CMS deems “appropriate” settings –  that also support the collection […]

The HIMSS Continuity of Care Maturity Model (CCMM) encompasses health from prenatal to end-of-life care, explains Toni Laracuente, SVP and head of Analytics at HIMSS.